Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Aims To 'Pierce The Rhetoric' On Generic Application Backlog

Oct 31 2016

• By Sue Sutter

Related Content

Generic Drug First-Cycle Approval Rates Lagging Under GDUFA I

Oct 26 2016

ANDA Approvals, Complete Responses Hit Record In FY 2016

Oct 12 2016

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

Mar 21 2016

Generic User Fee Renewal Talks Faced 'Buyer's Remorse' From GDUFA I

Oct 27 2016

FDA Meets ANDA Backlog Goal Early, Still Doesn't Feel Out Of Woods

Jul 12 2016

Additional Topics

United States Regulation Generic Drugs Drug Review BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window